trending Market Intelligence /marketintelligence/en/news-insights/trending/4kZgcexrc_CFYCJLqWDkjg2 content esgSubNav
In This List

Report: Sale of KKR's life-sciences testing company LGC may fetch more than $2B

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Podcast

Street Talk Episode 87

Blog

A New Dawn for European Bank M&A Top 5 Trends

Blog

Insight Weekly: US banks' loan growth; record share buybacks; utility M&A outlook


Report: Sale of KKR's life-sciences testing company LGC may fetch more than $2B

Healthcare companies Thermo Fisher Scientific Inc. and Danaher Corp., along with multiple private equity firms including Blackstone Group Inc., CVC Capital Partners Ltd. and EQT AB, are interested in buying KKR & Co.'s scientific measurement and testing company, LGC Group, Bloomberg News reported, citing anonymous sources.

New York-based private equity giant KKR may get more than $2 billion. This would include debt from the sale of LGC Group, which develops technology for the healthcare and agri-food sectors, the sources told Bloomberg News.

KKR is working with advisers to evaluate a potential sale of the business it acquired from British buyout firm Bridgepoint Advisers Ltd. in 2016. LGC, formerly known as Laboratory of the Government Chemist, was first taken private in 1996.

Spokespersons for Blackstone, CVC, EQT, KKR and Thermo Fisher declined to comment, according to Bloomberg News.